Cardiomyopathy - A hypersensitivity reaction of the myocardium to a drug Factor
Last reviewed for CCPS 18 July 2007.
Investigative Documents
Medical Report - Hypersensitivity Reaction of the Myocardium to a Drug - Cardiomyopathy [MR9107]
Preliminary questions [21575]
there is some evidence that a hypersensitivity reaction of the myocardium to a drug may be a factor in the development or worsening of the condition under consideration.25857 the veteran has had a hypersensitivity reaction of the myocardium to a drug at some time.
the veteran had a hypersensitivity reaction of the myocardium to a drug that was given for an illness or injury which is identifiable.21577 — the veteran has established the causal connection between the hypersensitivity reaction of the myocardium to a drug and VEA service for cardiomyopathy.
the drug, given as treatment for the identified illness or injury, caused the hypersensitivity reaction of the myocardium at the time of the clinical onset of the condition under consideration.21578 — the veteran has established the causal connection between the hypersensitivity reaction of the myocardium to a drug and VEA service for the clinical onset of cardiomyopathy.
21580 — the veteran has established the causal connection between the hypersensitivity reaction of the myocardium to a drug and operational service for the clinical onset of cardiomyopathy.
or
21581 — the veteran has established the causal connection between the hypersensitivity reaction of the myocardium to a drug and eligible service for the clinical onset of cardiomyopathy.
or
the clinical onset of the condition under consideration occurred after the end of the veteran's last period of VEA service. the condition under consideration permanently worsened. the drug, given as treatment for the identified illness or injury, caused the hypersensitivity reaction of the myocardium at the time of the clinical worsening of the condition under consideration.21579 — the veteran has established the causal connection between the hypersensitivity reaction of the myocardium to a drug and VEA service for the clinical worsening of cardiomyopathy.
21582 — the veteran has established the causal connection between the hypersensitivity reaction of the myocardium to a drug and operational service for the clinical worsening of cardiomyopathy.
or
21583 — the veteran has established the causal connection between the hypersensitivity reaction of the myocardium to a drug and eligible service for the clinical worsening of cardiomyopathy.
Clinical onset and operational service [21580]
21595 — the identified illness or injury, for which the drug that caused the hypersensitivity reaction of the myocardium was given, is causally related to operational service.
Clinical onset and eligible service [21581]
21596 — the identified illness or injury, for which the drug that caused the hypersensitivity reaction of the myocardium was given, is causally related to eligible service.
Clinical worsening and operational service [21582]
21595 — the identified illness or injury, for which the drug that caused the hypersensitivity reaction of the myocardium was given, is causally related to operational service.
the clinical onset of the condition under consideration occurred prior to that part of operational service to which the identified illness or injury, for which the drug that caused the hypersensitivity reaction of the myocardium was given, is causally related.Clinical worsening and eligible service [21583]
21596 — the identified illness or injury, for which the drug that caused the hypersensitivity reaction of the myocardium was given, is causally related to eligible service.
the clinical onset of the condition under consideration occurred prior to that part of eligible service to which the identified illness or injury, for which the drug that caused the hypersensitivity reaction of the myocardium was given, is causally related.